Waldencast PLC (NASDAQ:WALD) Receives $5.11 Consensus Price Target from Brokerages

Key Points

• Waldencast PLC has received a consensus recommendation of "Moderate Buy" from analysts, with one hold rating and five buy ratings from six research firms.
• The average 12-month price target for Waldencast shares is $5.11, indicating potential growth based on current market assessments.
• Notably, institutional investments have increased significantly, particularly with JPMorgan Chase & Co. boosting its stake by 116.3% in the fourth quarter.

Shares of Waldencast PLC (NASDAQ:WALD - Get Free Report) have been given an average rating of "Moderate Buy" by the six brokerages that are presently covering the company, Marketbeat reports. One investment analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is $5.11.

A number of equities analysts have recently commented on WALD shares. Telsey Advisory Group cut their price target on Waldencast from $5.00 to $4.00 and set an "outperform" rating for the company in a report on Thursday, May 15th. Canaccord Genuity Group cut their price target on Waldencast from $6.00 to $5.00 and set a "buy" rating for the company in a report on Thursday, May 15th. Wall Street Zen lowered Waldencast from a "hold" rating to a "sell" rating in a report on Thursday, May 22nd. Industrial Alliance Securities set a $5.00 price target on Waldencast in a report on Tuesday, April 22nd. Finally, Alliance Global Partners reaffirmed a "buy" rating on shares of Waldencast in a report on Thursday, May 15th.

Institutional Trading of Waldencast

Several large investors have recently modified their holdings of the business. Stonebrook Private Inc. bought a new stake in Waldencast during the 4th quarter valued at approximately $48,000. Ethic Inc. bought a new stake in Waldencast during the 4th quarter valued at approximately $56,000. McAdam LLC bought a new stake in Waldencast during the 2nd quarter valued at approximately $56,000. Wells Fargo & Company MN boosted its position in Waldencast by 29.9% during the 4th quarter. Wells Fargo & Company MN now owns 14,571 shares of the company's stock valued at $59,000 after acquiring an additional 3,358 shares in the last quarter. Finally, XTX Topco Ltd bought a new stake in Waldencast during the 4th quarter valued at approximately $70,000. 41.97% of the stock is owned by institutional investors.

Waldencast Price Performance

NASDAQ WALD traded down $0.08 on Thursday, hitting $1.70. 132,540 shares of the stock traded hands, compared to its average volume of 86,084. The business's fifty day moving average is $2.40 and its two-hundred day moving average is $2.77. Waldencast has a 12 month low of $1.68 and a 12 month high of $4.74. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.35 and a quick ratio of 0.66.

Waldencast Company Profile

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.